LifeVest® ranks #1 in patient compliance at 23.4+ hours/day based on peer-reviewed publications and real-world ...

Financing led by DreamCIS will accelerate and expand development of the company's industry-leading integrated platform, ...

New Scientist has shut its dedicated job board, New Scientist Jobs. This increases the presence of PharmiWeb in the niche ...

GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...

The global medical equipment maintenance market is expected to grow at a compound annual growth rate (CAGR) of 8-10% over the ...

Pharmaceutical REMS Market SizeThe global pharmaceutical REMS market — a critical safety framework for high‑risk drugs — is ...

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Study Highlights First-ever Demonstration of Protection Against B. pertussis Colonization in HumansWESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech ...

Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launched a GMP PFAS ...

NVIDIA technology is now integrated into several of GE HealthCare’s new imaging solutions, including Photonova Spectra1, SIGNA Sprint with Freelium2, SIGNA Bolt3, Vivid Pioneer, and Pristina Recon DL.

CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid sparing inhibitor of prostaglandin mediated inflammation, announced today that preliminary safety data ...